Spectrum Pharmaceuticals (SPPI) Coverage Initiated at Cantor

Cantor Fitzgerald started coverage on shares of Spectrum Pharmaceuticals (NASDAQ:SPPI) in a research report sent to investors on Thursday, February 7th, Marketbeat reports. The firm issued an overweight rating and a $19.00 target price

https://www.fairfieldcurrent.com/news/2019/02/16/spectrum-pharmaceuticals-sppi-coverage-initiated-at-cantor-fitzgerald.html